Refuge Biotechnologies

About:

Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.

Website: https://refugebiotech.com/

Top Investors: HongShan, DHVC, 3E Bioventures, 3SBio Inc., Shangbay Capital

Description:

Refuge is a cancer immunotherapy company leveraging synthetic biology and gene engineering to unlock the full promise of cell therapies. We create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously – resulting in more potent and targeted treatments beyond a single target and function.